Spanish Red Biotech Pipeline

MSD

Pembrolizumab/Lenvatinib

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Lenvatinib plus Pembrolizumab for First Line Therapy of Advanced HCC
Phase: 3Phase III in Spain, 2Phase II, 1Phase I